← Back to Search

Function-Based Elopement Treatment (FBET) for Autism Spectrum Disorder (FBET Trial)

N/A
Waitlist Available
Led By Mindy Scheithauer, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 16, week 28
Awards & highlights

FBET Trial Summary

This trial will test if FBET, a treatment for ASD and elopement, is effective. 76 children will be randomized to either FBET or a control group receiving PEP. Results will help researchers understand if FBET is an effective treatment.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

FBET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 16, week 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 16, week 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in Aberrant Behavior Checklist - Hyperactivity (ABC-H) Subscale Score
Change in Clinical Global Impression - Improvement (CGI-I) Score
Change in Home Elopement Safety Checklist (HESC) Score
+1 more
Other outcome measures
Change in Aberrant Behavior Checklist - Irritability (ABC-I) Scale Score

FBET Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Function-Based Elopement Treatment (FBET)Experimental Treatment1 Intervention
Participants in this group will receive Function-Based Elopement Treatment (FBET) for 16 weeks.
Group II: Parent Education Program (PEP)Active Control1 Intervention
Participants in this group will take part in a parent education program (PEP) for 16 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Function-Based Elopement Treatment (FBET)
2019
N/A
~80

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,497 Total Patients Enrolled
23 Trials studying Autism Spectrum Disorder
21,589 Patients Enrolled for Autism Spectrum Disorder
Autism SpeaksOTHER
35 Previous Clinical Trials
3,752 Total Patients Enrolled
19 Trials studying Autism Spectrum Disorder
2,325 Patients Enrolled for Autism Spectrum Disorder
Mindy Scheithauer, PhDPrincipal Investigator - Emory University
Emory University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

If an individual is not yet 50 years old, can they still participate in this research project?

"Children aged 4 to 12 years old are eligible to participate in this study."

Answered by AI

How many people suffering from this condition will be given the chance to participate in this clinical trial?

"That is accurate. The information available on clinicaltrials.gov does show that the recruitment process for this trial is still underway. The trial was established on May 9th, 2019 and the last update was on June 20th, 2022. They are looking for 76 individuals total from one location."

Answered by AI
~13 spots leftby Apr 2025